EFFICACY AND SAFETY OF SUBCUTANEOUS VERSUS INTRAVENOUS TOCILIZUMAB IN COMBINATION WITH TRADITIONAL DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS: 49 WEEK SUMMACTA DATA

被引：0
|
作者：
Burmester, Gerd R. [1 ,2 ,3 ]
Rubbert-Roth, Andrea [4 ]
Cantagrel, Alain [5 ]
Hall, Stephen [6 ]
Leszczynski, Piotr [7 ]
Feldman, Daniel [8 ]
Rangaraj, Madura J. [9 ]
Roane, Georgia [10 ]
Ludivico, Charles [11 ]
Mysler, Eduardo F. [12 ]
Wells, Chris [13 ]
Bennett, Melanie [13 ]
Vranic, Ivana [13 ]
机构：
[1] Charite, D-13353 Berlin, Germany
[2] Free Univ Berlin, Berlin, Germany
[3] Humboldt Univ, D-10099 Berlin, Germany
[4] Klinikum Univ Koln, Dept Internal Med, Cologne, Germany
[5] Ctr Hosp Univ Toulouse, Dept Rheumatol, Toulouse, France
[6] Cabrini Med Ctr, Dept Rheumatol, Malvern, Australia
[7] Poznan Univ Med Sci, Dept Physiotherapy Rheumatol & Rehabil, Poznan, Poland
[8] Univ Fed Sao Paulo, Dept Rheumatol, Sao Paulo, Brazil
[9] Arthrit & Diabet Clin Inc, Arthrit & Diabet Clin, Monroe, LA USA
[10] Rheumatol Associates, Dept Rheumatol, Charleston, SC USA
[11] East Penn Rheumatol Associates, Dept Rheumatol, Bethlehem, PA USA
[12] Org Med Invest, Dept Rheumatol, Buenos Aires, DF, Argentina
[13] Roche Prod Ltd, Dept Med, Garden City, Herts, England
来源：
RHEUMATOLOGY | 2014年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O22
引用
收藏
页码：37 / 38
页数：2
相关论文
共 50 条
  • [21] THE EFFECT OF BODYWEIGHT ON RESPONSE TO INTRAVENOUS OR SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Davies, R.
    Vivekanantham, A.
    Lunt, M.
    Watson, K.
    Hyrich, K.
    Bluett, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 981 - 981
  • [22] Efficacy and safety of tocilizumab in elderly patients with rheumatoid arthritis
    Pers, Yves-Marie
    Schaub, Roxane
    Constant, Elodie
    Lambert, Joseph
    Godfrin-Valnet, Marie
    Fortunet, Clementine
    Bourichi, Waafa
    Prades, Beatrice Pallot
    Wendling, Daniel
    Gaudin, Philippe
    Jorgensen, Christian
    Maillefert, Jean-Francis
    Marotte, Hubert
    JOINT BONE SPINE, 2015, 82 (01) : 25 - 30
  • [23] EFFICACY AND SAFETY OF TOCILIZUMAB IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS
    Pers, Y. -M.
    Schaub, R.
    Fortunet, C.
    Constant, E.
    Lambert, J.
    Godfrin-Valnet, M.
    Pallot-Prades, B.
    Wendling, D.
    Gaudin, P.
    Marotte, H.
    Maillefert, J. -F.
    Jorgensen, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 689 - 689
  • [24] PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SUBCUTANEOUS TOCILIZUMAB COMPARED WITH PLACEBO OR INTRAVENOUS TOCILIZUMAB IN COMBINATION WITH CSDMARDS
    Strand, V.
    Lampl, K.
    Birchwood, C.
    Pei, J.
    Tuckwell, K.
    Finch, R.
    Kivitz, A.
    Burmester, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 581 - 582
  • [25] Evaluation of switching from intravenous to subcutaneous formulation of tocilizumab in patients with rheumatoid arthritis
    Iwamoto, Naoki
    Fukui, Shoichi
    Umeda, Masataka
    Nishino, Ayako
    Nakashima, Yoshikazu
    Suzuki, Takahisa
    Horai, Yoshiro
    Nonaka, Fumiaki
    Okada, Akitomo
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Fujikawa, Keita
    Aramaki, Toshiyuki
    Ichinose, Kunihiro
    Hirai, Yasuko
    Tamai, Mami
    Nakamura, Hideki
    Terada, Kaoru
    Nakashima, Munetoshi
    Mizokami, Akinari
    Origuchi, Tomoki
    Eguchi, Katsumi
    Ueki, Yukitaka
    Kawakami, Atsushi
    MODERN RHEUMATOLOGY, 2016, 26 (05) : 662 - 666
  • [26] Subcutaneous Tocilizumab Versus Placebo in Combination With Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis
    Kivitz, Alan
    Olech, Ewa
    Borofsky, Michael
    Zazueta, Beatriz M.
    Navarro-Sarabia, Federico
    Radominski, Sebastiao C.
    Merrill, Joan T.
    Rowell, Lucy
    Nasmyth-Miller, Clare
    Bao, Min
    Wright, Stephen
    Pope, Janet E.
    ARTHRITIS CARE & RESEARCH, 2014, 66 (11) : 1653 - 1661
  • [27] Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis
    Baek, Han Joo
    Lim, Mie Jin
    Park, Won
    Park, Sung Hwan
    Shim, Seung-Cheol
    Yoo, Dae-Hyun
    Kim, Hyun Ah
    Lee, Soo Kon
    Lee, Yun Jong
    Park, Young Eun
    Cha, Hoon-Suk
    Song, Yeong-Wook
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (04): : 917 - 931
  • [28] The Efficacy and Safety of Tocilizumab Subcutaneous Q2W and Following Escalation from Q2W to QW Therapy in Combination with Traditional Dmards in Patients with Moderate to Severe Rheumatoid Arthritis at 96 Weeks.
    Kivitz, Alan
    Olech, Ewa
    Borofsky, Michael A.
    Zazueta, Beatriz M.
    Navarro-Sarabia, Federico
    Radominski, S. C.
    Merrill, Joan T.
    Pei, Jinglan
    Rowell, Lucy
    Nasmyth-Miller, Clare
    Wimalasundera, Sunethra
    Pope, Janet E.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1076 - S1077
  • [29] A Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy of Tocilizumab SC Versus Tocilizumab IV, in Combination with Traditional Dmards in Patients with Moderate to Severe RA.
    Burmester, G. R.
    Rubbert-Roth, Andrea
    Cantagrel, Alain G.
    Hall, Stephen
    Leszczynski, Piotr
    Feldman, Daniel
    Rangaraj, Madura J.
    Roane, Georgia
    Ludivico, Charles L.
    Ramirez, Francesco
    Bao, Min
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1075 - S1075
  • [30] SAFETY, TOLERABILITY AND EFFICACY OF SUBCUTANEOUS TOCILIZUMAB ADMINISTERED AS MONOTHERAPY OR IN COMBINATION WITH CSDMARDS IN RHEUMATOID ARTHRITIS: RESULTS FROM THE OSCAR STUDY
    Safy, M.
    De Hair, M. J.
    Borm, M. E.
    Kok, M. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 324 - 325
12345